The Atlantic :press: on Nostr: Psychedelic Medicine’s Biggest Dreams Are Fading The FDA did not approve the first ...
Published at
2024-08-11 16:07:56Event JSON
{
"id": "debf6cf3a1968eee4ebc72dae9ba338b5cd28b2f780a6435c064a11716d2aa7e",
"pubkey": "736ac37ea560e091b7bd858c82be3f252cf024d94d579cd5bda142134abeb2c1",
"created_at": 1723392476,
"kind": 1,
"tags": [
[
"t",
"press"
],
[
"proxy",
"https://press.coop/users/TheAtlantic/statuses/112944249305547372",
"activitypub"
]
],
"content": "Psychedelic Medicine’s Biggest Dreams Are Fading\n\nThe FDA did not approve the first psychedelic therapy it considered—which could make the field re-think its approach. #press\n\nhttps://www.theatlantic.com/health/archive/2024/08/mdma-fda-rejection/679438/?utm_source=press.coop\n\nhttps://cdn.theatlantic.com/thumbor/d59o65TnjyIZwiLoXdViJYIGMck=/media/img/mt/2024/08/HR_129369648/original.jpg",
"sig": "157bdf2e324c58ca3a000948f5e7b47ca0f59667f24bdc4f022b8f562f2a55a39055168519f7a6a89750d3765eb325df7021ce3213cbb7bae0c981defb4f2807"
}